Implants: Tools for Providers
October 2007 Issue No. 15	The INFO Project • Johns Hopkins Bloomberg School of Public Health • Center for Communication Programs • 111 Market Place, Suite 310 • Baltimore, Maryland 21202, USA • 410-659-6300 • 410-659-6266 (fax) • www.infoforhealth.org • infoproject@jhuccp.org

Counseling Clients About Implants Medical Eligibility Criteria Checklist for Implants Checklist: Providing Implants, With Appropriate Infection Prevention Practices Tool: Counseling About Changes in Monthly Bleeding Insertion and Removal of the New Implants Questions and Answers About Implants Tool: Implant Reminder Card Sources Subscription and Ordering Information How to Use This Report Credits

Sources

The links included in this report were upto- date at the time of publication. This bibliography includes citations to the materials most helpful in the preparation of this report.

1. BRUCE, J. Fundamental elements of the quality of care: A simple framework. Studies in Family Planning 21(2): 61-91. Mar.-Apr. 1990
2. CHIKAMATA, D.M. and MILLER, S. Health services at the clinic level and implantable contraceptives for women. Contraception 65(1): 97-106. Jan. 2002.
3. EDWARDS, J.E. and MOORE, A. Implanon. A review of clinical studies. British Journal of Family Planning 24(4 Suppl.): 3-16. Jan. 1999.
4. ENGENDERHEALTH. Infection prevention: A reference booklet for health care practitioners. New York, EngenderHealth, 2001. 75 p. (Available: http://www.engenderhealth.org/res/offc/safety/ip-ref/pdf/ip-ref-eng.pdf)
5. FOLCH-LYON, E., DE LA MACORRA, L., and SCHEARER, S.B. Focus group and survey research on family planning in Mexico. Studies in Family Planning 12(12 Pt 1): 409-432. Dec. 1981.
6. HAN, L., FAN, H., GONG, Q., XIE, Z., MENG, F., HONG, Y., and WANG, W. Effects of three types of longacting contraceptive implants on menstrual blood loss in 89 women. Reproduction and Contraception 10(2): 91-97. 1999.
7. HICKEY, M. and D’ARCANGUES, C. Vaginal bleeding disturbances and implantable contraceptives. Contraception 65(1): 75-84. Jan. 2002.
8. MCINTOSH, N., RISEBOROUGH, P., and DAVIS, C., eds. Norplant® guidelines for family planning service programs: A problem-solving reference manual. Baltimore, JHPIEGO, Jan. 1993.
9. ORGANON. Implanon® Clinician’s Manual. 1999. 64 p.
10. ORGANON. Implanon® Product Monograph. 2005. 84 p.
11. POPULATION COUNCIL. «Norplant® II» levonorgestrel implants (Jadelle®). New York, 2005. 50 p. (Available: http://www.popcouncil.org/licensing/20544se2-003_jadelle_lbl.pdf)
12. SIVIN, I. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants. Drug Safety 26(5): 303-335. 2003.
13. SIVIN, I., NASH, H., and WALDMAN, S. Jadelle® levonorgestrel rod implants: A summary of scientific data and lessons learned from programmatic experience. New York, Population Council, 2002. 48 p. (Available: http://list.popcouncil.org/pdfs/jadelle_monograph.pdf)
14. STEINER, M.J., TRUSSELL, J., MEHTA, N., CONDON, S., SUBRAMANIAM, S., and BOURNE, D. Communicating contraceptive effectiveness: A randomized controlled trial to inform a World Health Organization family planning handbook. American Journal of Obstetrics and Gynecology 195(1): 85-91. Jul. 2006.
15. THORN, N.T., HIEU, D.T., NHAN, V.Q., NHAN, D.T., WHITTAKER, M., FAJANS, P., and SATIA, J. The strategic approach to the introduction of DMPA as an opportunity to improve quality of care for all contraceptive methods in Viet Nam. Asia-Pacific Population Journal 15(4): 63-88. Dec. 2000.
16. WORLD HEALTH ORGANIZATION (WHO), REGIONAL OFFICE FOR SOUTH-EAST ASIA, and REGIONAL OFFICE FOR WESTERN PACIFIC. Practical guidelines for infection control in health care facilities. World Health Organization, 2004. 103 p. (Available: http://www.wpro.who.int/NR/rdonlyres/006EF250-6B11-42B4-BA17-C98D413BE8B8/0/practical_guidelines_infection_control.pdf)
17. WORLD HEALTH ORGANIZATION DEPARTMENT OF REPRODUCTIVE HEALTH AND RESEARCH (WHO/ RHR) and JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH/CENTER FOR COMMUNICATION PROGRAMS (CCP). Family planning: A global handbook for providers. Baltimore and Geneva, CCP and WHO, 2007. (Available: www.fphandbook.org)
18. ZHENG, S.R., ZHENG, H.M., QIAN, S.Z., SANG, G.W., and KAPER, R.F. A long-term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon) in healthy women in China. European Journal of Contraception and Reproductive Health Care 4(2): 85-93. Jun. 1999.

Previous | Next
Top of Page

Information & Knowledge for Optimal Health (INFO) Project
111 Market Place Suite 310, Baltimore, MD 21202
Phone: 410-659-6300  Fax: 410-659-6266 Security & Privacy Policy